Is IEMT a Placebo Therapy?

The honest answer is that current research cannot yet determine how much change associated with IEMT is specific to its procedures and how much arises from expectation, attention, memory recall, therapeutic contact or other contextual factors.

Review the current research

Research and articles hub

The short answer

Calling IEMT “just placebo” goes beyond the evidence. Claiming that its active procedures have been shown to work beyond placebo also goes beyond the evidence. The question remains open and can only be answered by appropriately designed comparative studies.

What does “placebo” mean here?

The phrase placebo therapy is imprecise. In research, a placebo or sham condition is used to help separate an intervention’s specific effects from changes associated with receiving care, expecting improvement, repeating measurements, the natural course of a problem and other influences.

A placebo response is not the same as pretending, lying or imagining symptoms. People can report genuine changes in pain, distress or other subjective experiences. Those changes do not, however, demonstrate that the theory or distinctive procedure offered by a practitioner caused them.

A large Cochrane review of placebo interventions found no major health benefits overall, although modest effects occurred on some patient-reported outcomes, with considerable variation. Placebo should therefore be understood as a research and contextual phenomenon, not as a universal hidden cure.

Contextual influences

Expectation and treatment credibility
Attention and therapeutic contact
Repeated recall or exposure
Time, measurement and spontaneous change

Specific effects

A specific effect is the additional change attributable to the intervention being tested after relevant comparison factors have been controlled as well as possible.

IEMT has not yet been tested adequately in this way.

Why a structured technique is not automatically “beyond placebo”

IEMT contains recognisable procedures: clients attend to an emotional experience or memory, follow directed eye movements, respond to questions and may discuss recurring patterns. These are real activities rather than an inert pill. Their existence does not establish which element caused any reported improvement, whether the distinctive elements add benefit, or whether change lasts.

The same caution applies to psychoeducation and the Five Patterns of Chronicity. They may help organise a conversation or draw attention to recurring responses. They are not validated mechanisms, and presenting an explanation to a client can itself influence expectation and interpretation.

Component evidence is not whole-treatment evidence. Findings from studies of EMDR, working memory, exposure, recall or eye movements can help form hypotheses. They cannot be transferred to IEMT as proof that its complete method is effective.

What does the current IEMT study show?

The 2026 exploratory study involved 33 adults recalling negative memories while completing either an IEMT-directed or EMDR-directed eye-movement pattern. It measured immediate changes in emotionality and distress. The findings are useful as preliminary experimental data.

The study did not evaluate full IEMT or full EMDR therapy. It did not recruit people for treatment of a diagnosed condition, compare IEMT with a credible sham or no-treatment group, establish lasting benefit, identify a mechanism, or provide a sufficient basis for safety conclusions.

It therefore cannot answer whether IEMT produces outcomes beyond placebo or other contextual effects. Read the full study explanation or view the published journal article.

Can IEMT be tested fairly?

Yes. A psychotherapy or practitioner-delivered technique is difficult to double-blind because the practitioner usually knows what is being delivered and participants may recognise aspects of it. That does not prevent rigorous research. Trials of non-pharmacological interventions can use credible comparison conditions, masked outcome assessors, blinded data analysis and transparent checks on whether masking was successful.

Research on blinding and sham controls in non-pharmacological trials shows both the difficulty and the available methods. “Not possible to double-blind” should not be used as a reason to abandon comparison or bias control.

What a useful IEMT trial would include

A preregistered protocol and predefined primary outcome
An adequate sample and transparent eligibility criteria
A credible comparison controlling for time, attention, recall and expectation
Standardised delivery and checks on practitioner fidelity
Validated measures, masked assessment where possible and meaningful follow-up
Adverse-event, deterioration, dropout and non-response reporting
Independent replication, including publication of negative findings

What should practitioners say now?

A responsible explanation is simple: IEMT is an emerging technique. Some people report helpful changes, but research is currently too limited to determine its effectiveness for specific conditions or whether its distinctive procedures add benefit beyond contextual effects. Results cannot be guaranteed.

Practitioners should not claim that IEMT “neutralises trauma”, “depotentiates memories” or activates a proven neurological mechanism as established facts. They should explain their qualifications, the limits of the evidence, possible discomfort, alternatives and what will happen if the client becomes more distressed or needs other care.

If you are considering IEMT

Do not stop or delay medical or mental-health care because of IEMT.
Ask about the practitioner’s wider qualifications, insurance and scope.
Agree what will be measured and what would count as benefit, no change or deterioration.
You may pause or stop a session and withdraw consent at any time.
Use the Association’s complaints and adverse-event route if something goes wrong.

Complaints and adverse events

Find a registered member